Pfizer today released its 2015 integrated annual review, which is an in-depth look at the company’s financial, social and environmental performance. Read More »

Pfizer recently published the results to its Phase 3 study of BeneFIX Coagulation Factor IX (recombinant) 100 IU/kg prophylaxis compared to on-demand treatment for patients with moderately severe or severe hemophilia B. Read More »

McKesson has announced the release of Conserus Imaging Fellow. Read More »

Robert M. Califf, M.D., will be appointed the new commissioner of the U.S. Food and Drug Administration (FDA) after the Senate recently voted in favor of his appointment, 89-4. Read More »

The US Oncology Network has announced the launch of a new groundbreaking program that was developed to aid oncologists from around the country prepare for the execution of the new Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) and other alternate payment models. Read More »

Endocare Inc. has announced it has signed an exclusive agreement with R-Action Distribution Sarl, which is a subsidiary of R-Action SAS, that will allow the distribution of its Endocare Cryoablation technology in France and Switzerland. Read More »

McKesson Corp. announced this week that it has agreed to terms to buy Vantage Oncology LLC and Biologics Inc. Read More »

Pfizer Inc. announced last week that the United States Food and Drug Administration (FDA) has approved the expanded use of the drug IBRANCE (palbociclib). Read More »

RelayHealth Financial announced last week a comprehensive agenda for the HIMSS16 Conference and Exhibition that will aid financial leaders in the health care industry to hurdle obstacles that disturb payments when the financial and clinical processes are not interconnected. Read More »

McKesson announced this week that it has renewed health care IT services with Saint Anthony Hospital, based in Chicago, Illinois, and Cookeville Regional Medical Center (CRMC), located in Tennessee. Read More »

McKesson Specialty Health announced this week that the Scottsdale Area Chamber of Commerce has awarded its Reimbursement, Access & Services Solution Center the Sterling Award. Read More »

BodyMcKesson announced this week that KLAS, an independent health research firm, has named McKesson Labs 2015/2016 Best in KLAS for Laboratory. Read More »

Pfizer has announced that an agreement has been reached by its subsidiary, Wyeth, to resolve claims that its practice in calculating Medicaid rebates violated the Federal Civil False Claims Act and other laws. Read More »

US Oncology Research announced recently that it has found and recruited its 2,000th patient to take part in a Phase I clinical trial through its Translational Oncology Program (TOP). Read More »

Pfizer Inc. has commended the United States Food and Drug Administration (FDA) Arthritis Advisory Committee for its recommendation to approve the biosimilar infliximab (CT-P13) this week. Read More »

Lafayette Radiology, a radiology group based in Lafayette, Indiana, announced last week that will begin utilizing McKesson Business Performance Services in order to help its staff adjust to ICD-10. Read More »

Livanta announced last week that it has agreed to the long-term use of InterQual to ensure and review the quality of care for Medicare beneficiaries, including short-stay patients. Read More »

Bristol-Myers Squibb and Pfizer announced this week that the companies have agreed to a cooperative effort with Portola Pharmaceuticals to develop and commercialize andexanet alpha. Read More »

Keystone Peer Review Organization Inc. (KEPRO) announced this week that it has agreed to its continued use of InterQual on a long-term basis. Read More »

McKesson Pharmacy Systems & Automation (MPS&A) has announced the release of its new technological platform, the McKesson Clinical Programs Solution, which is designed to help pharmacists tailor wellness plans to patients with specific needs. Read More »